<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04955158</url>
  </required_header>
  <id_info>
    <org_study_id>17101486</org_study_id>
    <nct_id>NCT04955158</nct_id>
  </id_info>
  <brief_title>Dexmedetpmidine Versus Ketamine for Postoperative Sore Throat in Sinus Surgery</brief_title>
  <official_title>Impact of Dexmedetomidine Versus Ketamine Soaked Pharyngeal Packing on Postoperative Sore Throat in Functional Endoscopic Sinus Surgery: a Randomized Double Blind Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized clinical trial is to evaluate the impact of dexmedetomidine versus&#xD;
      ketamine soaked pharyngeal packing on postoperative sore throat in functional endoscopic&#xD;
      sinus surgery (FESS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A written informed consent was taken from the patients.patients will be randomly assigned to&#xD;
      three groups of 40 subjects each; dexmedetomidine or ketamine or saline soaked pharyngeal&#xD;
      packs were situated under direct vision. Throat packs made of gauze with a length of 20 cm&#xD;
      and a width of 10 cm (folded transverse four times) and medications were diluted with 20 ml&#xD;
      normal saline. The packings were placed by the surgeon blinded to the study groups.&#xD;
&#xD;
      1-Dexmedetomidine group: 75 µg dexmedetomidine soaked pharyngeal pack (Group D) putted in the&#xD;
      posterior pharyngeal wall after induction of anesthesia and &amp; endotracheal tube (ETT).&#xD;
&#xD;
      2-Ketamine group: 50 mg ketamine soaked pharyngeal pack (Group K) putted in the posterior&#xD;
      pharyngeal wall after induction of anesthesia and ETT.&#xD;
&#xD;
      3-Control group: 20 ml 0.9% saline soaked pharyngeal pack (Group C) putted in the posterior&#xD;
      pharyngeal wall after induction of anesthesia and ETT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 19, 2021</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 22, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of postoperative sore throat (POST)</measure>
    <time_frame>24 hour after surgery</time_frame>
    <description>On arrival in the post anesthesia care unit, the patient was immediately evaluated for the presence of sore throat (time 0 hour) using a standardized scale. The severity of POST was graded on a 4-point scale ranging from 0 to 3; 0 being no sore throat, 1 being mild discomfort (complains only with questioning), 2 being moderate sore throat (complains on their own), and 3 being severe sore throat (change in voice, hoarseness, and throat pain). Evaluations occurred at 0, 1, 2, 4, 6, 12 and 24 hours postoperatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting (PONV) score</measure>
    <time_frame>2 hours postoperative</time_frame>
    <description>PONV score was assessed and documented using a Verbal Descriptive Scale, which correlates to visual analog nausea scores, with an objective measure of severity: 0 = no PONV: patient reports no nausea and has had no emesis episodes; 1 = mild PONV: patient reports nausea but declines antiemetic treatment; 2 = moderate PONV: patient reports nausea and accepts antiemetic treatment; and 3 = severe PONV: nausea with any emesis episode (retching or vomiting). The score was obtained at 0, 30, 60, 90, and 120 minutes after PACU arrival; 4 mg IV ondansetron for occurred nausea &amp; vomiting.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Sore Throat</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>75 µg dexmedetomidine soaked pharyngeal pack</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 mg ketamine soaked pharyngeal pack</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20 ml 0.9% saline soaked pharyngeal pack</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>75 µg dexmedetomidine soaked pharyngeal pack (Group D) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.</description>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <other_name>Precedex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>50 mg ketamine soaked pharyngeal pack (Group K) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.</description>
    <arm_group_label>Ketamine</arm_group_label>
    <other_name>ketalar</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline 0.9%</intervention_name>
    <description>20 ml 0.9% saline soaked pharyngeal pack (Group C) putted in the posterior pharyngeal wall after induction of anesthesia and ETT.</description>
    <arm_group_label>Saline placebo</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults of both sex with American Society of Anesthesiologists (ASA) physical status&#xD;
             I-II&#xD;
&#xD;
          -  Elective functional endoscopic sinus surgery (FESS) with endotracheal intubation.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  A history of preoperative sore throat.&#xD;
&#xD;
          -  Upper respiratory tract illness&#xD;
&#xD;
          -  Potentially difficult airway&#xD;
&#xD;
          -  Patients with history of neck, respiratory or digestive tract pathology&#xD;
&#xD;
          -  Chronic smokers&#xD;
&#xD;
          -  Using steroid within the last 48 hour&#xD;
&#xD;
          -  Pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omar Soliman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Omar makram</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Omar Soliman, MD</last_name>
    <phone>01101266040</phone>
    <email>omarmakram347@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Omar Soliman</name>
      <address>
        <city>Assuit</city>
        <zip>Assuit universi</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Omar Soliman</last_name>
      <phone>01101266040</phone>
      <email>omarmakram347@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Higgins PP, Chung F, Mezei G. Postoperative sore throat after ambulatory surgery. Br J Anaesth. 2002 Apr;88(4):582-4.</citation>
    <PMID>12066737</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>July 1, 2021</study_first_submitted>
  <study_first_submitted_qc>July 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 8, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Omar Makram Soliman</investigator_full_name>
    <investigator_title>Lecturer of anesthesia and ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

